Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — December 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • nohopeN Offline
    nohopeN Offline
    nohope
    wrote on sidst redigeret af
    #383

    Regn med kursen stiger - jeg har nemlig lige solgt....

    1 Reply Last reply
    0
    • D Offline
      D Offline
      Doublo
      wrote on sidst redigeret af
      #384

      Ja og telefonen ringede så jeg fik lige akkurat IKKE solgt!

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #385

        ASH 2020 Highlights – Diffuse Large B Cell Lymphoma (DLBCL) https://prescienthg.com/resources/2020/12/04/ash-2020-diffuse-large-b-cell-lymphoma-dlbcl/ (can also click on
        MM)

        1 Reply Last reply
        0
        • nohopeN Offline
          nohopeN Offline
          nohope
          wrote on sidst redigeret af
          #386

          Jeg understøtter kursen på GEN ved at sælge, det er undtagelsesfrit, at den stiger, når jeg sælger.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #387

            New Dara trial https://clinicaltrials.gov/ct2/show/NCT04656951?term=NCT04656951&draw=2&rank=1

            1 Reply Last reply
            0
            • D Offline
              D Offline
              Doublo
              wrote on sidst redigeret af
              #388

              Pensionisten du må undskylde hvis vi har overtrådt nogen regler?

              1 Reply Last reply
              0
              • J Offline
                J Offline
                JohnW
                wrote on sidst redigeret af
                #389

                Så sælg lidt flere @nohope 🙂

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #390

                  New DARZALEX® (daratumumab) Data from GRIFFIN Study Show Deeper and Longer Responses in Patients with Newly Diagnosed Multiple Myeloma https://www.prnewswire.com/news-releases/new-darzalex-daratumumab-data-from-griffin-study-show-deeper-and-longer-responses-in-patients-with-newly-diagnosed-multiple-myeloma-301187387.html

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #391

                    Data from the ANDROMEDA Study Show Hematologic Response for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Newly Diagnosed Light Chain (AL) Amyloidosis https://www.prnewswire.com/news-releases/data-from-the-andromeda-study-show-hematologic-response-for-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-in-newly-diagnosed-light-chain-al-amyloidosis-301187390.html

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #392

                      Ritzau: https://www.proinvestor.com/investornyt/670148/genmab-sydbank-saerdeles-positive-data-fra-nyt-studie

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #393

                        FiercePharma -ASH: Johnson & Johnson shores up Darzalex's myeloma lead with another subcutaneous win https://www.fiercepharma.com/pharma/ash-johnson-johnson-shores-up-darzalex-s-myeloma-lead-another-subcutaneous-win

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #394

                          Griffin , looking at the patients from the safety run-in phase, after 24 months 94%sCR....

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #395

                            Dr Mark Wildgust: GRIFFIN Findings Show Adding Daratumumab to Induction, Maintenance Regimens Improves Rate, Depth of Response https://www.ajmc.com/view/dr-mark-wildgust-griffin-findings-show-adding-daratumumab-to-induction-maintenance-regimens-improves-rate-depth-of-response

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #396

                              Bloomberg Markets @markets
                              Biotech stocks rallied to a record Monday in reaction to a deluge of data on blood disease treatments presented at the American Society of Hematology https://trib.al/dm8Ce0l

                              1 Reply Last reply
                              0
                              • K Offline
                                K Offline
                                Klarussen
                                wrote on sidst redigeret af
                                #397

                                De glemte at nævne Genmab…

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  peter12
                                  wrote on sidst redigeret af
                                  #398

                                  Der skal nok komme købere. Der nogen der ved hvad den skal koste, og det er den bedste forsikring vi kan få 😉

                                  1 Reply Last reply
                                  0
                                  • D Offline
                                    D Offline
                                    DevOp
                                    wrote on sidst redigeret af
                                    #399

                                    Epco viser virkelig høj ORR og safety i en heavily pretreated pts population - normalt ville det jo være en kurstrigger. Men se lige tilbage på dara indtjening, og hvor meget, vi faktisk skulle se penge på kontoen, før kursen fulgte efter.

                                    1 Reply Last reply
                                    0
                                    • A Offline
                                      A Offline
                                      AaBforever
                                      wrote on sidst redigeret af
                                      #400

                                      De er åbenbart også i vildrede i US.

                                      1 Reply Last reply
                                      0
                                      • A Offline
                                        A Offline
                                        AaBforever
                                        wrote on sidst redigeret af
                                        #401

                                        GMAB i minus.

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #402

                                          Data var gode og det skal nok drive kursen fremover. I dag og andre dage kan det være andre ting, der driver kursen. US omsætningen er kun 1/10 af DK omsætningen og derfor noget man ikke skal hænge sig så meget i. Husker US faldt den aften vi fik daras første pivotal trial offentliggjort. Dagen efter var der fest i Kbh 😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger